Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aristada once-monthly (aripiprazole lauroxil once-monthly formulation) / Alkermes
NCT01493726: A Study of ALKS 9072 in Subjects With Chronic Stable Schizophrenia

Checkmark P1 data, ECNP 2012
Oct 2012 - Oct 2012: P1 data, ECNP 2012
Completed
1
88
US
ALKS 9072, Low dose, ALKS 9072, Med dose, ALKS 9072, High dose, Placebo
Alkermes, Inc.
Schizophrenia
06/13
06/13
NCT02320032: An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia

Completed
1
140
US
Aripiprazole Lauroxil
Alkermes, Inc.
Schizophrenia
04/16
04/16

Download Options